Option Care Health, Inc. (OPCH): Price and Financial Metrics


Option Care Health, Inc. (OPCH)

Today's Latest Price: $19.64 USD

0.05 (0.26%)

Updated Jan 25 6:55pm

Add OPCH to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 77 in Medical - Services

See all "A" rated Strong Buy stocks

OPCH Stock Summary

  • The price/operating cash flow metric for Option Care Health Inc is higher than 83.39% of stocks in our set with a positive cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, Option Care Health Inc is reporting a growth rate of -709.67%; that's higher than only 2.75% of US stocks.
  • As for revenue growth, note that OPCH's revenue has grown 152.04% over the past 12 months; that beats the revenue growth of 96.04% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Option Care Health Inc, a group of peers worth examining would be FLL, UFAB, GT, AGO, and CMLS.
  • Visit OPCH's SEC page to see the company's official filings. To visit the company's web site, go to www.optioncarehealth.com.

OPCH Stock Price Chart Interactive Chart >

Price chart for OPCH

OPCH Price/Volume Stats

Current price $19.64 52-week high $19.90
Prev. close $19.59 52-week low $5.74
Day low $19.03 Volume 540,800
Day high $19.77 Avg. volume 683,773
50-day MA $16.15 Dividend yield N/A
200-day MA $13.86 Market Cap 3.67B

Option Care Health, Inc. (OPCH) Company Bio


Option Care Health, Inc. provides infusion and home care management solutions. The Company offers products, services, and condition-specific clinical management programs for gastrointestinal abnormalities, infectious diseases, cancer, organ and blood cell transplants, bleeding disorders, and heart failures. Option Care Health serves patients in the United States.


OPCH Latest News Stream


Event/Time News Detail
Loading, please wait...

OPCH Latest Social Stream


Loading social stream, please wait...

View Full OPCH Social Stream

Latest OPCH News From Around the Web

Below are the latest news stories about Option Care Health Inc that investors may wish to consider to help them evaluate OPCH as an investment opportunity.

Option Care Health Announces Issuance of $250 Million in Additional First Lien Term Loan and Concurrent Extinguishment of All Outstanding Second Lien Notes

BANNOCKBURN, Ill., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: OPCH)(“Option Care Health” or the Company”), the nation’s largest independent home and alternate site infusion services provider, announced today that it has successfully issued $250 million in additional first lien term loans, the proceeds from which were used to extinguish the entire $246 million remaining outstanding balance of the Company’s second lien notes. The terms of the additional first lien term loans, including the maturity date of August 2026, are consistent with the Company’s existing first lien credit agreement. The Company’s existing first lien term loans currently bear interest at Libor plus 4.25%; however, subsequent to the effective date of the incurrence of the incremental term loan...

Yahoo | January 21, 2021

What You Need To Know About Option Care Health, Inc.'s (NASDAQ:OPCH) Investor Composition

Every investor in Option Care Health, Inc. ( NASDAQ:OPCH ) should be aware of the most powerful shareholder groups...

Yahoo | January 20, 2021

Leading Healthcare Services Organizations Collaborate to Provide Innovative COVID Therapy Access Model

BATON ROUGE, La., and BANNOCKBURN, Ill., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, and Option Care Health Inc. (NASDAQ: OPCH), the nation’s largest independent home and alternate site infusion services provider, are collaborating on providing COVID antibody infusion therapy within skilled nursing and assisted living facilities, collectively referred to as “long term care facilities.” The U.S Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUAs) to both Eli Lilly and Regeneron for their investigational neutralizing antibody therapies to treat mild to moderate COVID-19 in adults and pediatrics who are at high risk for progressing to severe COVID-19 symptoms or hospitalization. ...

Yahoo | January 5, 2021

Is OPCH A Good Stock To Buy Now?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]

Yahoo | December 16, 2020

Option Care Health Announces Financial Results for the Second Quarter

BANNOCKBURN, Ill., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2020. Given the merger between HC Group Holdings II, Inc. (“Option Care”) and BioScrip, Inc. (“BioScrip”) to form Option Care Health on August 6, 2019, comparisons to historical periods are relative to legacy Option Care only and incorporate BioScrip results from August 6, 2019 prospectively. Further, as reported on February 3, 2020, the Company completed a reverse 1-for-4 stock split in the first quarter and, as a result, all per share data below is reported incorporating the effect of the revers...

Yahoo | August 4, 2020

Read More 'OPCH' Stories Here

OPCH Price Returns

1-mo N/A
3-mo 45.16%
6-mo 64.90%
1-year 14.19%
3-year 65.88%
5-year 188.82%
YTD 25.58%
2020 4.83%
2019 4.48%
2018 22.68%
2017 179.81%
2016 -40.57%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8296 seconds.